Here's Why You Should Hold Ingersoll Rand (IR) in Your Portfolio

Core Insights - Ingersoll Rand Inc. is positioned to leverage its diversified market presence to offset weaknesses in specific sectors [1] - The company anticipates a revenue growth of 14-16% year over year for 2023, with organic revenue growth projected at 9-11% [1] - Recent acquisitions, including Oxywise and Fraserwoods, are expected to enhance capabilities in high-growth markets [1] - The company expects acquisitions to contribute an additional $360 million to revenues in 2023 [2] Financial Performance - Ingersoll Rand's free cash flow increased by 60.2% year over year to $720.2 million in the first nine months of 2023 [2] - The company returned value to shareholders through $24.3 million in dividends and $132.8 million in share repurchases during the same period [2] - The company experienced a 12.7% increase in cost of sales and a 14.9% rise in selling and administrative expenses in the first nine months of 2023 [3] Market Challenges - The Precision & Science Technologies segment faced a revenue decline of 1.8% on a reported basis and 5.3% organically due to weak demand in the life sciences sector [3] - Rising costs and operating expenses have been a concern, impacting overall profitability [3] Comparative Performance - Ingersoll Rand's stock has gained 33.4% over the past three months, outperforming the industry average growth of 21.4% [2]